These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12593470)

  • 21. The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India.
    Kumarasamy N; Solomon S; Chaguturu SK; Cecelia AJ; Vallabhaneni S; Flanigan TP; Mayer KH
    Clin Infect Dis; 2005 Nov; 41(10):1525-8. PubMed ID: 16231268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?
    Vella S; Palmisano L
    J HIV Ther; 2003 May; 8(2):27-8. PubMed ID: 15587479
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
    Leonard EG; McComsey GA
    Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.
    Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA
    AIDS; 2008 May; 22(9):1093-4. PubMed ID: 18520357
    [No Abstract]   [Full Text] [Related]  

  • 26. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE
    Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
    HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
    [No Abstract]   [Full Text] [Related]  

  • 28. Switch therapy studies.
    Mallon PW
    J HIV Ther; 2001 May; 6(2):45-8. PubMed ID: 11505945
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.
    Palacios R; Santos J; García A; Castells E; González M; Ruiz J; Márquez M
    HIV Med; 2006 Jan; 7(1):10-5. PubMed ID: 16313287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors.
    Montes ML; Pulido F; Barros C; Condes E; Rubio R; Cepeda C; Dronda F; Antela A; Sanz J; Navas E; Miralles P; Berenguer J; Pérez S; Zapata A; González-García JJ; Peña JM; Vázquez JJ; Arribas JR
    J Antimicrob Chemother; 2005 May; 55(5):800-4. PubMed ID: 15761071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical worsening of ocular tuberculosis in HIV patients after antiretroviral therapy.
    Rathinam SR; Lalitha P
    Eye (Lond); 2007 May; 21(5):667-8. PubMed ID: 17139273
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strange side effects.
    TreatmentUpdate; 2002 Nov; 14(8):3. PubMed ID: 12501821
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antiretroviral treatment of HIV infected patients].
    Lichterfeld M; Rockstroh JK
    Med Monatsschr Pharm; 2003 Apr; 26(4):111-21; quiz 121-2. PubMed ID: 12722525
    [No Abstract]   [Full Text] [Related]  

  • 35. [General practice as part of HIV patient management. Doctor, I am HIV positive!].
    Bogner JR
    MMW Fortschr Med; 2003 Jul; 145(29-30):31. PubMed ID: 12958774
    [No Abstract]   [Full Text] [Related]  

  • 36. [HIV patients in general practice. What should be noted?].
    Gey D; Ellwanger B; Stephan M; Lüer S; Hartmann M
    MMW Fortschr Med; 2003 Jul; 145(29-30):32-6. PubMed ID: 12958775
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV infection in older patients in the HAART era.
    Grabar S; Weiss L; Costagliola D
    J Antimicrob Chemother; 2006 Jan; 57(1):4-7. PubMed ID: 16284223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV, HAART and dentistry: what you need to know.
    O'Halloran M; Hogan J; Flint SR
    J Ir Dent Assoc; 2006; 52(1):18-22. PubMed ID: 16830835
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug interactions. Introduction: careful combinations.
    TreatmentUpdate; 2006; 18(3):1-2. PubMed ID: 17209235
    [No Abstract]   [Full Text] [Related]  

  • 40. Sexual dysfunction in the highly active antiretroviral therapy era.
    Collazos J
    AIDS Rev; 2007; 9(4):237-45. PubMed ID: 18219367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.